Healthcare provider profile · identity verified

Clay D Vincent, APRN

Nurse Practitioner · LEITCHFIELD, KY · NPI 1881026425

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	651	176
Amlodipine Besylate	Amlodipine Besylate	584	140
Levothyroxine Sodium	Levothyroxine Sodium	506	120
Pravastatin Sodium	Pravastatin Sodium	442	119
Gabapentin	Gabapentin	440	96
Pantoprazole Sodium	Pantoprazole Sodium	438	123
Losartan Potassium	Losartan Potassium	429	106
Metformin Hcl	Metformin Hcl	380	100
Omeprazole	Omeprazole	369	97
Tamsulosin Hcl	Tamsulosin Hcl	334	78
Lisinopril	Lisinopril	331	84
Sertraline Hcl	Sertraline Hcl	308	75
Potassium Chloride	Potassium Chloride	289	81
Hydrochlorothiazide	Hydrochlorothiazide	248	66
Rosuvastatin Calcium	Rosuvastatin Calcium	240	65
Furosemide	Furosemide	229	68
Metoprolol Succinate	Metoprolol Succinate	223	62
Glimepiride	Glimepiride	178	40
Carvedilol	Carvedilol	176	43
Montelukast Sodium	Montelukast Sodium	175	43
Allopurinol	Allopurinol	173	40
Ezetimibe	Ezetimibe	172	46
Metoprolol Tartrate	Metoprolol Tartrate	172	49
Meloxicam	Meloxicam	171	40
Methylprednisolone	Methylprednisolone	162	130
Eliquis	Apixaban	158	31
Clopidogrel	Clopidogrel Bisulfate	154	38
Fluticasone Propionate	Fluticasone Propionate	150	64
Diclofenac Sodium	Diclofenac Sodium	144	44
Tramadol Hcl	Tramadol Hcl	143	32
Albuterol Sulfate Hfa	Albuterol Sulfate	140	42
Baclofen	Baclofen	132	39
Trazodone Hcl	Trazodone Hcl	132	31
Hydroxyzine Hcl	Hydroxyzine Hcl	130	35
Alprazolam	Alprazolam	127	18
Atenolol	Atenolol	123	32
Simvastatin	Simvastatin	112	27
Bupropion Hcl Sr	Bupropion Hcl	105	28
Isosorbide Mononitrate Er	Isosorbide Mononitrate	96	22
Buspirone Hcl	Buspirone Hcl	90	21
Lorazepam	Lorazepam	89	13
Fluoxetine Hcl	Fluoxetine Hcl	82	20
Finasteride	Finasteride	81	20
Synthroid	Levothyroxine Sodium	80	19
Warfarin Sodium	Warfarin Sodium	78	16
Duloxetine Hcl	Duloxetine Hcl	76	18
Jardiance	Empagliflozin	71	16
Primidone	Primidone	65	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	62	14
Escitalopram Oxalate	Escitalopram Oxalate	61	18
Ropinirole Hcl	Ropinirole Hcl	58	13
Meclizine Hcl	Meclizine Hcl	57	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	12
Mounjaro	Tirzepatide	56	suppressed
Ozempic	Semaglutide	56	18
Famotidine	Famotidine	54	16
Nitroglycerin	Nitroglycerin	53	29
Diazepam	Diazepam	51	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	12
Spironolactone	Spironolactone	49	15
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Alendronate Sodium	Alendronate Sodium	48	13
Fluconazole	Fluconazole	47	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	34
Azithromycin	Azithromycin	46	42
Pregabalin	Pregabalin	45	suppressed
Xarelto	Rivaroxaban	45	11
Clonazepam	Clonazepam	43	suppressed
Glipizide	Glipizide	43	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	14
Dicyclomine Hcl	Dicyclomine Hcl	42	13
Indapamide	Indapamide	42	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	suppressed
Ventolin Hfa	Albuterol Sulfate	41	suppressed
Celecoxib	Celecoxib	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	13
Hydralazine Hcl	Hydralazine Hcl	39	12
Quetiapine Fumarate	Quetiapine Fumarate	38	12
Temazepam	Temazepam	38	suppressed
Sucralfate	Sucralfate	37	15
Torsemide	Torsemide	37	11
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Colestipol Hcl	Colestipol Hcl	34	suppressed
Donepezil Hcl	Donepezil Hcl	34	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	11
Glipizide Er	Glipizide	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Propranolol Hcl	Propranolol Hcl	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	13
Mirtazapine	Mirtazapine	28	suppressed
Mupirocin	Mupirocin	28	18
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	21
Ondansetron Odt	Ondansetron	27	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Valsartan	Valsartan	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	25	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	25	suppressed
Glyburide	Glyburide	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Novolog	Insulin Aspart	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	20
Ibuprofen	Ibuprofen	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Novolin N	Insulin Nph Human Isophane	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Linzess	Linaclotide	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Naproxen	Naproxen	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Tadalafil	Tadalafil	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Digoxin	Digoxin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Estradiol	Estradiol	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Levofloxacin	Levofloxacin	13	12
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Nystatin	Nystatin	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error